The University of Oxford has launched the first study to assess the safety and immune responses in children and young adults of its coronavirus vaccine. The university said that previous trials of......
Backing the 12-16 weeks gap between the two doses of Covishield in the country, the chief investigator of the AstraZeneca vaccine clinical trials on Friday said that the level of protection......
The coronavirus vaccine developed by Oxford University and AstraZeneca shows promise as it can generate both antibodies and cell-mediated immune responses, say several scientists in India and......
A large trial in the United States and two South American countries of the Oxford-AstraZeneca vaccine has shown 79 per cent efficacy rate at preventing symptomatic COVID-19 and 100 per cent......
The sudden spike in cases of fever in India has claimed over 100 lives in five states, including UP, MP, Bihar, Haryana, and West Bengal. In UP, Firozabad and Mathura alone have reported 72 cases.......